Chitosan and its derivatives as nanocarriers for siRNA delivery

被引:14
|
作者
Al-Qadi, S. [1 ]
Grenha, A. [2 ]
Remunan-Lopez, C. [1 ]
机构
[1] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Nanobiofar Grp, Santiago De Compostela 15782, Spain
[2] Univ Algarve, IBB Inst Biotechnol & Bioengn, CBME Ctr Mol & Struct Biomed, Faro, Portugal
关键词
Chitosan; Chitosan derivatives; Formulation parameters; Gene silencing; Nanocarriers; siRNA delivery; SMALL INTERFERING RNA; TARGETED GENE DELIVERY; NUCLEIC-ACID DELIVERY; MOLECULAR-WEIGHT; IN-VITRO; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; ANTIINFLAMMATORY TREATMENT; NANOPARTICLE FORMULATION; INTRAVENOUS DELIVERY;
D O I
10.1016/S1773-2247(12)50003-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability to specifically silence genes using siRNA has enormous potential for treating genetic diseases. However, siRNA instability and biodistribution issues still need to be overcome, and adequate delivery vehicles have proven indispensable in conveying siRNA to its target. Chitosan is a promising biopolymer for siRNA delivery, its interest stemming from its solely, biodegradability, mucoadhesivity, permeation enhancing effect and cationic charge, as well as amenability to undergo chemical modifications. Chitosan and its derivatives can be readily arranged into complexes or nanoparticles able to entrap and carry siRNA. Specific strategies have been adopted to improve chitosan-based vectors with regard to transfectability. However, further efforts cure required to verify their value and adapt them to enhance therapeutic output prior to clinical application. This review emphasizes the potential of chitosan and its derivatives to develop nanocarriers for siRNA delivery. The properties of chitosan that are significant for transfectability and the most relevant findings are assessed.
引用
收藏
页码:29 / 42
页数:14
相关论文
共 50 条
  • [41] Chitosan and its derivatives as intraocular penetration enhancers
    Zambito, Y.
    Di Colo, G.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2010, 20 (01) : 45 - 52
  • [42] Chitosan nanocarriers for non-coding RNA therapeutics: A review
    Karthik, S.
    Mohan, Sahithya
    Magesh, Induja
    Bharathy, Ashok
    Kolipaka, Rushil
    Ganesamoorthi, Srinidhi
    Sathiya, K.
    Shanmugavadivu, Abinaya
    Gurunathan, Raghav
    Selvamurugan, N.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 263
  • [43] NANOCARRIERS FOR DELIVERY OF SIRNA AS GENE SILENCING MEDIATOR
    Morales-Becerril, Aidee
    Aranda-Lara, Liliana
    Isaac-Olive, Keil A.
    Ocampo-Garcia, Blanca E.
    Morales-Avilaa, Enrique
    EXCLI JOURNAL, 2022, 21 : 1028 - 1052
  • [44] O-substituted Tertiary Amine-chitosans as Promising Nanocarriers for siRNA Delivery
    Martinez Jr, Andre Miguel
    de Oliveira, Vera Aparecida
    Tiera, Marcio Jose
    CURRENT GENE THERAPY, 2025,
  • [45] Using Chitosan or Chitosan Derivatives in Cancer Therapy
    Shakil, Md Salman
    Mahmud, Kazi Mustafa
    Sayem, Mohammad
    Niloy, Mahruba Sultana
    Halder, Sajal Kumar
    Hossen, Md. Sakib
    Uddin, Md. Forhad
    Hasan, Md. Ashraful
    POLYSACCHARIDES, 2021, 2 (04): : 795 - 816
  • [46] Polymeric Nanocarriers for siRNA Delivery to Murine Macrophages
    Forbes, Diane C.
    Peppas, Nicholas A.
    MACROMOLECULAR BIOSCIENCE, 2014, 14 (08) : 1096 - 1105
  • [47] Chitosan-based siRNA delivery systems
    Ragelle, Heloise
    Vandermeulen, Gaelle
    Preat, Veronique
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : 207 - 218
  • [48] Chitosan-Based Nanocarriers for Nose to Brain Delivery
    Aderibigbe, Blessing Atim
    Naki, Tobeka
    APPLIED SCIENCES-BASEL, 2019, 9 (11):
  • [49] SiRNA Delivery: challenges and role of carrier systems
    Shegokar, R.
    Al Shaal, L.
    Mishra, P. R.
    PHARMAZIE, 2011, 66 (05): : 313 - 318
  • [50] ORAC of chitosan and its derivatives
    Casettari, Luca
    Gennari, Lorenzo
    Angelino, Donato
    Ninfali, Paolino
    Castagnino, Enzo
    FOOD HYDROCOLLOIDS, 2012, 28 (02) : 243 - 247